Precision BioLogic’s principal focus is in the field of hemostasis for which we developed CRYOcheck™, a line of specialized high-quality frozen plasmas, reagents and integrated test kits used in the assessment of coagulation disorders. From our facility in Dartmouth, we currently serve more than 1,000 labs throughout North America with direct overnight delivery, and work with distribution partners to sell to customers overseas.
In conjunction with our laboratory, biotech and pharmaceutical partners, we’re also developing new products to improve patient outcomes by addressing current and future challenges in the diagnosis and therapeutic monitoring of disease.
140 Eileen Stubbs Avenue
Dartmouth, NS B3B 0A9
- ACOA: Precision BioLogic Inc. Banks on Developing New Diagnostic Tools
- News Release: Precision BioLogic Appoints President and CEO
- News Release: Precision BioLogic Launches Product to Improve Inhibitor Testing for People with Hemophilia A
- Precision BioLogic Acquires Affinity Biologicals
- Precision BioLogic Becomes First Diagnostics Company to Commit to Supporting the World Federation of Hemophilia Humanitarian Aid Program